Skip to main content
. 2022 Aug 19;18(6):503–513. doi: 10.4244/EIJ-D-21-01048

Table 3. Procedure characteristics and outcomes by ARC-HBR status.

HBR+ N=633 HBR– N=154 p-value
Procedure performed 620/633 (97.9%) 151/154 (98.1%) >0.99
Total procedure time (min) 72±36 77±37 0.18
Total contrast volume administered (mL) 132±53 135±70 0.51
General anaesthesia 88/620 (14.2%) 28/151 (18.5%) 0.20
Type of access Percutaneous 616/619 (99.5%) 151/151 (100.0%) 0.39
Surgical cut-down 3/619 (0.5%) 0/151 (0.0%)
Sheathless 235/620 (37.9%) 52/151 (34.4%) 0.45
Suture device closure for main access site No 5/619 (0.8%) 1/151 (0.7%) 0.92
ProStar 131/619 (21.2%) 29/151 (19.2%)
1 ProGlide 34/619 (5.5%) 7/151 (4.6%)
2 ProGlide 335/619 (54.1%) 88/151 (58.3%)
Other 114/619 (18.4%) 26/151 (17.2%)
Predilatation balloon valvuloplasty 370/620 (59.7%) 93/151 (61.6%) 0.71
Size device (mm) 27±2 26±2 0.08
Post-dilatation 248/620 (40.0%) 68/151 (45.0%) 0.27
Procedural complications 84/620 (13.5%) 28/151 (13.2%) >0.99
Valve malpositioning 5/620 (0.8%) 6/151 (4.0%) 0.01
Coronary artery obstruction 2/620 (0.3%) 0/151 (0.0%) >0.99
Haemodynamic instability 9/620 (1.5%) 0/151 (0.0%) 0.21
Cardiac tamponade 7/620 (1.1%) 1/151 (0.7%) >0.99
Annular rupture 1/620 (0.2%) 1/151 (0.7%) 0.35
Conversion to open heart surgery 2/620 (0.3%) 0/151 (0.0%) >0.99
Access vessel complication 48/620 (7.7%) 9/151 (6.0%) 0.60
Bleeding 16/620 (2.6%) 1/151 (0.7%) 0.22
Intraprocedural death 3/620 (0.5%) 0/151 (0.0%) >0.99
Number of events (percentages). ARC-HBR: Academic Research Consortium - High Bleeding Risk; min: minutes; mL: millilitres; mm: millimetres